| Dr Muhammad S Hanif, MD | |
|
664 Broadway, Bayonne, NJ 07002-4726 | |
| (201) 292-7575 | |
| Not Available |
| Full Name | Dr Muhammad S Hanif |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 26 Years |
| Location | 664 Broadway, Bayonne, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487792503 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Ozanam Hall Of Queens Nursing Home Inc | Bayside, NY | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cogent Healthcare Of New Jersey Pc | 6608918867 | 4 |
| Cooper Physician Offices Pa | 2860396611 | 241 |
| Hospitalist Medicine Physicians Of Ohio, Professional Corporation | 3779749197 | 139 |
| Hospitalist Medicine Physicians Of Pennsylvania Pc | 9234309840 | 39 |
News Archive
Historically, males have been considered the vulnerable sex, sometimes called "male vulnerability." Charles Darwin noted that boys are more likely to die in infancy than girls and have a higher risk of premature death throughout their lifetimes. Now, a researcher at the University of Missouri suggests that research in "male vulnerability" should be expanded to include "female vulnerability."
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED- test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Day in and day out, in our bodies, the DNA in cells is damaged for a variety of reasons, and thus intercellular DNA-repair systems are fundamental to the maintenance of life.
A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.
› Verified 4 days ago
| Entity Name | Cooper Physician Offices Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154369510 PECOS PAC ID: 2860396611 Enrollment ID: O20031122000067 |
News Archive
Historically, males have been considered the vulnerable sex, sometimes called "male vulnerability." Charles Darwin noted that boys are more likely to die in infancy than girls and have a higher risk of premature death throughout their lifetimes. Now, a researcher at the University of Missouri suggests that research in "male vulnerability" should be expanded to include "female vulnerability."
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED- test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Day in and day out, in our bodies, the DNA in cells is damaged for a variety of reasons, and thus intercellular DNA-repair systems are fundamental to the maintenance of life.
A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.
› Verified 4 days ago
| Entity Name | Sai Inpatient Resources, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336267004 PECOS PAC ID: 2668492711 Enrollment ID: O20051205000033 |
News Archive
Historically, males have been considered the vulnerable sex, sometimes called "male vulnerability." Charles Darwin noted that boys are more likely to die in infancy than girls and have a higher risk of premature death throughout their lifetimes. Now, a researcher at the University of Missouri suggests that research in "male vulnerability" should be expanded to include "female vulnerability."
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED- test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Day in and day out, in our bodies, the DNA in cells is damaged for a variety of reasons, and thus intercellular DNA-repair systems are fundamental to the maintenance of life.
A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.
› Verified 4 days ago
| Entity Name | Ipc Hospitalist Physicians Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639303159 PECOS PAC ID: 2769533165 Enrollment ID: O20090625000023 |
News Archive
Historically, males have been considered the vulnerable sex, sometimes called "male vulnerability." Charles Darwin noted that boys are more likely to die in infancy than girls and have a higher risk of premature death throughout their lifetimes. Now, a researcher at the University of Missouri suggests that research in "male vulnerability" should be expanded to include "female vulnerability."
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED- test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Day in and day out, in our bodies, the DNA in cells is damaged for a variety of reasons, and thus intercellular DNA-repair systems are fundamental to the maintenance of life.
A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.
› Verified 4 days ago
| Entity Name | Cogent Healthcare Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629304290 PECOS PAC ID: 6608918867 Enrollment ID: O20100126000691 |
News Archive
Historically, males have been considered the vulnerable sex, sometimes called "male vulnerability." Charles Darwin noted that boys are more likely to die in infancy than girls and have a higher risk of premature death throughout their lifetimes. Now, a researcher at the University of Missouri suggests that research in "male vulnerability" should be expanded to include "female vulnerability."
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED- test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Day in and day out, in our bodies, the DNA in cells is damaged for a variety of reasons, and thus intercellular DNA-repair systems are fundamental to the maintenance of life.
A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of New Jersey - Paterson, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821576455 PECOS PAC ID: 1153671383 Enrollment ID: O20180907002361 |
News Archive
Historically, males have been considered the vulnerable sex, sometimes called "male vulnerability." Charles Darwin noted that boys are more likely to die in infancy than girls and have a higher risk of premature death throughout their lifetimes. Now, a researcher at the University of Missouri suggests that research in "male vulnerability" should be expanded to include "female vulnerability."
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED- test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Day in and day out, in our bodies, the DNA in cells is damaged for a variety of reasons, and thus intercellular DNA-repair systems are fundamental to the maintenance of life.
A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muhammad S Hanif, MD 502 W Side Ave, Jersey City, NJ 07304-1528 Ph: (201) 423-0428 | Dr Muhammad S Hanif, MD 664 Broadway, Bayonne, NJ 07002-4726 Ph: (201) 292-7575 |
News Archive
Historically, males have been considered the vulnerable sex, sometimes called "male vulnerability." Charles Darwin noted that boys are more likely to die in infancy than girls and have a higher risk of premature death throughout their lifetimes. Now, a researcher at the University of Missouri suggests that research in "male vulnerability" should be expanded to include "female vulnerability."
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED- test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Day in and day out, in our bodies, the DNA in cells is damaged for a variety of reasons, and thus intercellular DNA-repair systems are fundamental to the maintenance of life.
A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.
› Verified 4 days ago
Dr. George Tarng, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 744 Broadway, Bayonne, NJ 07002 Phone: 201-436-8888 | |
Deborah M Wozniak, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 19 E 27th St, Bayonne, NJ 07002 Phone: 201-339-1414 Fax: 201-339-5427 | |
Dr. Jack Boghossian, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 631 Broadway, Bayonne, NJ 07002 Phone: 973-364-2682 Fax: 973-364-1430 | |
Danuta Silber, MD PHD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 740 Kennedy Blvd, Bayonne, NJ 07002 Phone: 201-858-0848 Fax: 201-858-1106 | |
Renee Trotter, APN Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Dr. Domonick Condo, Md, 622 Broadway, Bayonne, NJ 07002 Phone: 201-436-2800 | |
Vashti Wanda Ramphal, Internal Medicine Medicare: Medicare Enrolled Practice Location: 29 E 29th St, Bayonne, NJ 07002 Phone: 201-585-5000 | |
Dr. Dominick Condo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 622 Broadway, Bayonne, NJ 07002 Phone: 201-436-2800 Fax: 201-436-9840 |